source
- Lisata acquires Marea Therapeutics, securing $225M financing to advance two mid-stage drugsLisata Therapeutics completed a stock-for-stock acquisition of biotech startup Marea Therapeutics. The transaction includes a $225 million financing round led by existing backers such as Forbion,…
- FDA confronts surge of Chinese biotech firms as they become key industry playersThe FDA is currently assessing how to handle the rapid growth of biotech companies from China, which have moved from being economic competitors to important contributors in the pharmaceutical lands…